Facilitators and Barriers to Nurse Practitioners Prescribing Methadone for Opioid Use Disorder in Nova Scotia: A Qualitative Study.  Bates AE, Martin-Misener R.  Can J Nurs Res. 2021 Feb 20:844562121996222. doi: 10.1177/0844562121996222…

Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes.  Khan A, Khan Q, Kolb E.  J Subst Abuse Treat. 2021 Apr;123:108256. doi: 10.1016/j.jsat.2020.108256. Epub 2020 Dec 18. PMID: 336121…

Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.  Dela Cruz AM, Walker R, Pipes R, Wakhlu S, Trivedi MH. Addict Sci Clin Pract. 2021 Feb 19;16(1):12. doi: 10.1186/…

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report.  Guillou-Landreat M, Dany A, Challet-Bouju G, Laforgue E, Leboucher J, Benoit Hardouin J…

Linking opioid use disorder treatment from hospital to community.  Brothers, T. D., Lewer, D., and Thakrar, A. P. (2021)  Addiction, doi.org/10.1111/add.15460.  https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.15460

Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.  Dong H, Hayashi K, Milloy MJ, DeBeck K, Singer J, Wong H, Wood E, Kerr T. Drug Alcohol Depend. 2020 Jul 1;212:108005. doi: 10.10…